| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5832473 | International Immunopharmacology | 2015 | 7 Pages |
Abstract
sCD163 is a biomarker for the clinical assessment of macrophage proliferation and activity that would help in risk prediction of bone and lung involvement and monitoring treatment response.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Amira Abdel Moneam Adly, Eman Abdel Rahman Ismail, Taghreed Mahmoud Ibraheem,